Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand’s COOL-AF registry

Fig. 2

Rate of oral anticoagulant (OAC) use among 4 groups of patients according to the presence of coronary artery disease (CAD) and the use of antiplatelet (AP) for all patients (left) and high-risk patients (right). High-risk patients defined as male with CHA2DS2-VASc score ≥ 2 or female with CHA2DS2-VASc score ≥ 3

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us